deoxyglucose has been researched along with Diabetes Mellitus, Type 2 in 211 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (3.79) | 18.7374 |
| 1990's | 48 (22.75) | 18.2507 |
| 2000's | 61 (28.91) | 29.6817 |
| 2010's | 78 (36.97) | 24.3611 |
| 2020's | 16 (7.58) | 2.80 |
| Authors | Studies |
|---|---|
| Dagnelie, PC; Eussen, SJPM; Maasen, K; Opperhuizen, A; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; van der Kallen, CJH; van Greevenbroek, MMJ | 1 |
| Joo, SS; Kim, HS; Yoo, YM | 1 |
| Hao, M; Huang, X; Li, M; Li, W; Liu, W; Xu, Y; Yan, D | 1 |
| Alfieri, S; Di Giuseppe, G; Dibner, C; Giaccari, A; Guessous, I; Jiménez-Sánchez, C; Jornayvaz, FR; Li, L; Maechler, P; Mezza, T; Quero, G; Schrauwen, P; Sinturel, F | 1 |
| Neira Sánchez, ER; Poletti Ferrara, LF; Villena Chávez, JE | 1 |
| Colodner, R; Hasanein, J; Hissin, N; Mirsky, N; Nachum, Z; Shwartz, N; Twafra, S; Yefet, E | 1 |
| Alouffi, S; Khan, MWA | 1 |
| Bao, Y; He, X; Ma, X; Shen, Y; Su, H; Wang, Y; Ying, L; Zhou, J; Zhu, W | 1 |
| Ahmad, K; Choi, I; Lee, EJ; Lee, YH; Shaikh, S | 1 |
| Chen, C; Chen, J; Guo, H; Sun, Z; Tan, Y; Wang, B; Wang, X; Wang, Y; Yang, J; Yuan, Y | 1 |
| Ahmad, S; Farooqui, A; Husain, A; Khanam, A; Rehman, S; Yusuf, MA | 1 |
| Hao, S; Li, H; Li, J; Lou, Q; Miller, JD; Yan, J; Yang, L; Yuan, X; Zuo, P | 1 |
| Dai, XX; Gao, MX; Shi, GL; Su, G; Yao, WF; Zhang, T; Zhuang, SW | 1 |
| Bao, Y; Hu, G; Lu, J; Lu, W; Ma, X; Mo, Y; Shen, Y; Si, Y; Zhang, L; Zhou, J; Zhu, W | 1 |
| Hanssen, NMJ; Hovind, P; Parving, HH; Persson, F; Piazza, M; Rossing, P; Schalkwijk, CG; Scheijen, JL; Stehouwer, CDA; van de Waarenburg, MPH; van Greevenbroek, MMJ | 1 |
| Katsuno, T; Konishi, K; Koyama, H; Kusunoki, Y; Matsuo, T; Matsutani, S; Namba, M; Ohigashi, M; Osugi, K; Tsunoda, T; Washio, K | 1 |
| Adamski, J; Artati, A; Federici, M; Ghesquiere, B; Kappel, BA; Lehrke, M; Marx, N; Moellmann, J; Rau, M; Romeo, F; Schuett, K; Stoehr, R; Thiele, K | 1 |
| Boerwinkle, E; Friedrich, N; Köttgen, A; Li, M; Loomis, SJ; Maruthur, NM; Mei, H; Morrison, AC; Nauck, M; North, KE; Pankow, JS; Pietzner, M; Selvin, E; Teumer, A | 1 |
| Glodzik, W; Hohendorff, J; Kapusta, M; Kiec-Wilk, B; Klupa, T; Ludwig-Galezowska, A; Malecki, MT; Mrozinska, S; Parpan, T; Platek, T; Skupien, J; Szopa, M; Zapala, B | 1 |
| Szwergold, B | 1 |
| Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R | 1 |
| Díaz-Lobo, M; Fernández-Novell, JM | 1 |
| Bao, Y; He, X; Hu, X; Jia, W; Ma, X; Peng, J; Su, H; Wang, Y; Ying, L; Zhou, J | 1 |
| Bai, Y; Song, Y; Wang, Y; Yang, R | 1 |
| Chaudhuri, R; Fazakerley, DJ; Fisher-Wellman, KH; Hoehn, KL; James, DE; Krycer, JR; Kuncic, Z; Su, Z; Vafaee, F; Yang, JYH | 1 |
| Dang, LH; Ha, TKQ; Hoang, MC; Lee, CH; Nguyen, TBT; Oh, WK; Pham, HTT; Tran, VO | 1 |
| Gao, WY; Li, H; Liu, ZF; Ma, SB; Wang, XJ | 1 |
| Glodzik, W; Hohendorff, J; Kapusta, M; Klupa, T; Malecki, MT; Matejko, B; Sani, CM; Skupien, J; Szopa, M; Ucieklak, D; Zapala, B | 1 |
| Ahmadi, M; Barone-Rochette, G; Calizzano, A; Desruet, MD; Djaileb, L; Fagret, D; Ghezzi, C; Perret, P; Reboulet, G; Vanzetto, G | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M | 1 |
| Gao, WY; Li, H; Wang, XJ; Zhang, HX; Zhu, AH | 1 |
| Schalkwijk, CG; Scheijen, JL | 1 |
| Cao, Y; Chen, X; Himmeldirk, K; Kim, J; Li, Y; Liu, F; Liu, Y; Qian, Y; Ren, Y | 1 |
| Chin, SO; Choi, MC; Chon, S; Fraterrigo, G; Kim, YS; Kwon, MK; Lee, YJ; Oh, S; Pozzilli, P; Rhee, SY; Woo, JT | 1 |
| Balakrishnan, A; Bharath Prasad, AS; Joshi, MB; Lad, A; Ramachandra, L; Satyamoorthy, K | 1 |
| Aoyama, J; Igari, Y; Ishii, K; Matsumura, N; Motoyama, M; Nakano, H; Oba, K; Ouchi, M; Sekimizu, K; Suzuki, T; Watanabe, K; Yano, H | 1 |
| Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S | 1 |
| Liu, B; Shi, Y; Tang, L; Wang, J; Wang, Y; Wei, Q; Xu, H; Xu, W; Zhang, L; Zhao, G | 1 |
| Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
| Alenina, N; Bader, M; Braga, JF; Burghi, V; Dominici, FP; Giani, JF; Kotnik, K; Miquet, JG; Qadri, F; Santos, RA; Santos, SH; Todiras, M | 1 |
| Balis, DA; Meininger, G; Tong, C | 1 |
| Abdul Kader, S; Al Muftah, WA; Al-Homsi, H; Al-Mahmoud, KA; Al-Obaidli, A; Chidiac, OM; Karoly, ED; Kocher, T; McKeon, C; Mook-Kanamori, DO; Mook-Kanamori, MJ; Rowe, J; Sekkal Gherbi, W; Selim, MM; Suhre, K; Takiddin, AH; Yousri, NA; Zirie, MA | 1 |
| Borowska, M; Dworacka, M; Dworacki, G; Iskakova, S; Krzyżagórska, E; Wesołowska, A | 1 |
| Dworacka, M; Dworacki, G; Iskakova, S; Wesołowska, A; Winiarska, H; Wysocka, E | 1 |
| Mori, H; Okada, Y; Tanaka, Y; Torimoto, K | 1 |
| Aoki, C; Aso, Y; Kato, K; Niitani, M; Suzuki, K; Tanaka, S; Tomotsune, T | 1 |
| Bo, P; Fang, P; Guo, L; Shi, M; Yu, M; Zhang, Z | 1 |
| Parrinello, CM; Selvin, E | 1 |
| Chan, CL; Kelsey, M; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Hanssen, NM; Maessen, DE; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Bao, Y; Deng, Z; Hao, Y; Hu, X; Jia, W; Luo, Y; Ma, X; Zhou, J | 1 |
| Brown, Z; Gooley, TA; Hirsch, IB; Wright, LA | 1 |
| Brown, Z; Coley, RY; Delaney, SS | 1 |
| Chinnaiyan, M; Karundevi, B; Narasimhan, A | 1 |
| Avalos-Soriano, A; De la Cruz-Cordero, R; Duarte-Vázquez, MÁ; Garcia-Gasca, T; López-Martínez, FJ; Rosado, JL | 1 |
| Ako, J; Fujiyoshi, K; Hashikata, T; Hashimoto, T; Kakizaki, R; Kameda, R; Kitasato, L; Maekawa, E; Namba, S; Nemoto, T; Shimohama, T; Tojo, T; Yamaoka-Tojo, M | 1 |
| Amaya, N; Arakawa, K; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Sato, T; Shiomi, Y; Tada, H; Tama, N; Uzui, H | 1 |
| Fortuna, D; McCloskey, LJ; Stickle, DF | 1 |
| Hasslacher, C; Kulozik, F | 1 |
| Bergman, RN; Dorfman, MD; Kaiyala, KJ; Lantier, L; Matsen, ME; Mirzadeh, Z; Morton, GJ; Nguyen, HT; Rojas, JM; Scarlett, JM; Schwartz, MW; Stefanovski, D; Unterman, TG; Wasserman, DH | 1 |
| Chang, X; Cui, L; Liu, M; Sun, K | 1 |
| Jeon, WS; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
| Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H | 1 |
| Baumgartner, A; Chan, CL; Kelsey, MM; Nadeau, KJ; Newnes, L; Pyle, L; Zeitler, PS | 1 |
| Bahn, G; Beisswenger, PJ; Howell, S; Reaven, PD; Saremi, A; Schwenke, DC | 1 |
| Fokkens, BT; Los, LI; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ | 1 |
| Guo, M; Liu, Z; Ma, C; Sheng, J | 1 |
| Aoki, K; Nakajima, S; Nezu, U; Shinoda, K; Terauchi, Y | 1 |
| Heng, X; Li, S; Sheng, H; Wang, Y; Yu, C | 1 |
| Alonso-Castro, AJ; González-Chávez, MM; Miranda-Torres, AC; Salazar-Olivo, LA | 1 |
| Bilo, HJ; Diamant, M; Schindhelm, RK; Slingerland, RJ | 1 |
| Choi, ES; Kim, JH; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SW; Rhee, EJ; Won, JC | 1 |
| Babraj, JA; Chen, S; Cuthbertson, DJ; Green, K; Hardie, DG; Leese, G; Mustard, K; Rennie, MJ; Smith, K; Sutherland, C; Towler, MC | 1 |
| Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jiang, H; Martin, S; Wolffenbuttel, BH | 1 |
| Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Nakaoka, H; Senba, I; Sone, H | 1 |
| Kublaoui, BM; Oden, JD; Shah, S; White, PC | 1 |
| Aillaud, M; Asagami, T; Azuma, J; Deng, AC; Jin, H; Kundu, RK; Quertermous, T; Reaven, GM; Tsao, PS; Yue, P | 1 |
| Barrow, BA; Dudley, C; Farmer, AJ; Gloyn, AL; Grew, JP; Klyne, R; McCarthy, MI; Owen, KR; Pal, A; Selwood, MP | 1 |
| Anand, S; Balakrishnan, A; Lakshmi, BS; Muthusamy, VS; Nithya, N; Sangeetha, KN; Sujatha, S; Velmurugan, D | 1 |
| Blangero, J; Bozaoglu, K; Cameron-Smith, D; Carless, MA; Collier, GR; Curran, JE; Dyer, TD; Foletta, VC; Jowett, JB; Konstantopoulos, N; McAinch, AJ; Moses, EK; Prior, MJ; Segal, DH; Walder, KR | 1 |
| Berdichevsky, A; Bose, A; Guarente, L | 1 |
| Ban, N; Endo, K; Kawana, H; Miyashita, Y; Murano, T; Nagayama, D; Nagumo, A; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H; Yamaguchi, T | 1 |
| Hanafusa, T; Imagawa, A; Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H | 1 |
| Barto, R; Engelen, L; Ferreira, I; Gram, J; Lund, SS; Parving, HH; Pedersen, O; Schalkwijk, CG; Stehouwer, CD; Tarnow, L; Teerlink, T; Vaag, AA; Winther, K | 1 |
| Keers, JC; Kerstens, MN; Kreugel, G; Wolffenbuttel, BH | 1 |
| Rasmussen, SK; Wang, L; Wang, MH; Xu, ML | 1 |
| Cho, SW; Hwang-Bo, Y; Jang, HC; Jung, HS; Kim, MJ; Kim, SY; Park, KS | 1 |
| Davis, KE; Januszewski, AS; Jenkins, AJ; Karschimkus, C; O'Neal, D; Ward, G | 1 |
| Kishimoto, M; Noda, M | 1 |
| Kim, WJ; Lee, KB; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
| Lei, CH; Sun, ZL; Wang, Y; Wang, YP; Zhang, YL | 1 |
| Hamano, K; Ishibashi, S; Kiyono, K; Kusaka, I; Nagasaka, S; Ogata, H; Struzik, ZR; Suzuki, H; Tokuyama, K; Tsuchita, T; Yamada, N; Yamamoto, Y | 1 |
| Ahn, HY; Kim, SW; Kim, WJ; Kim, YJ; Lee, WY; Oh, KW; Park, CY; Park, HS; Park, SE; Park, SW; Rhee, EJ; Song, SJ | 1 |
| Dou, JT; Lu, JM; Lü, ZH; Ma, FL; Mu, YM; Sun, J; Wang, XL; Yang, GQ; Zheng, H | 1 |
| Arakaki, RF; Buse, JB; Dungan, KM; Fahrbach, JL; Herman, WH; Jacobson, JG; Jiang, HH | 1 |
| Bo, P; Guo, L; Li, G; Sheng, S; Shi, M; Zhang, L; Zhang, Z; Zhu, Y | 1 |
| Cao, X; Huang, Z; Li, Y; Liu, J; Liu, L; Wan, X | 1 |
| Kim, WJ; Park, CY | 1 |
| Ando, K; Irako, T; Nishimura, R; Sakamoto, M; Tsujino, D; Utsunomiya, K | 1 |
| Cai, W; Chen, X; Ramdas, M; Striker, GE; Vlassara, H; Zhu, L | 1 |
| Dungan, KM | 1 |
| Adachi, I; Ishikawa, F; Kato, A; Kunimatsu, T; Takeshita, K; Yamashita, Y | 1 |
| Dealtry, G; Koekemoer, T; Roux, S; van de Venter, M; Williams, S | 1 |
| Kajita, M; Nakamura, S; Niwa, T; Tsukushi, S | 1 |
| Dworacka, M; Kuczynski, S; Szczawinska, K; Szymanska, M; Wierusz-Wysocka, B; Winiarska, H | 1 |
| Cui, TX; Horiuchi, M; Iwai, M; Nakagami, H; Shiuchi, T; Takeda-Matsubara, Y; Wu, L | 1 |
| Becker, C; Bonen, A; Fischer, Y; Glatz, JF; Koonen, DP; Luiken, JJ; Tandon, NN; Van Der Vusse, GJ; Willems, J; Zorzano, A | 1 |
| Inoue, T; Kashiwabara, A; Kawasaki, T; Ogata, N; Sawashige, K; Sekino, N; Yamanouchi, T | 1 |
| Hong, SJ; Hsu, HK; Hwang, JH; Yang, YC | 1 |
| Bogan, JS; Hendon, N; Lodish, HF; McKee, AE; Tsao, TS | 1 |
| Araki, A; Sasamoto, K; Shirabe, S; Yamanouchi, T; Yanagawa, T | 1 |
| Cui, TX; Horiuchi, M; Iwai, M; Li, HS; Li, JM; Min, LJ; Okumura, M; Shiuchi, T; Wu, L | 1 |
| Akanuma, H; Ichiyanagi, K; Kawasaki, T; Ogata, N; Sakai, T; Watanabe, H; Yamanouchi, T | 1 |
| Ammirati, EB; Cole, TG; Gautille, T; Houghton, S; McGill, JB; Nowatzke, W; Sarno, MJ | 1 |
| Algenstaedt, P; Böttcher, A; Greten, H; Hansen-Algenstaedt, N; Kolb, I; Krützelmann, A; Rosenblatt, N; Schwarzloh, B; Wiesner, L | 1 |
| Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H | 1 |
| Feneberg, R; Lemmer, B | 1 |
| Huisamen, B; Lochner, A | 1 |
| Boucher, J; Boutin, JA; Carpéné, C; Ferry, G; Grès, S; Guigné, C; Pradères, JP; Prévot, D; Quilliot, D; Saulnier-Blache, JS; Simon, MF; Valet, P | 1 |
| Acitores, A; Arnés, L; González, N; Malaisse, WJ; Sancho, V; Valverde, I; Villanueva-Peñacarrillo, ML | 1 |
| Baynes, JW; Bleich, M; Busch, AE; Deemer, EK; Dingermann, T; Huber, J; Münch, G; Schäfer, S; Schmid, K; Somoza, V; Wihler, C | 1 |
| Armoni, M; Bar-Yoseph, F; Harel, C; Karnieli, E; Milo, S | 1 |
| González, N; Malaisse, WJ; Martín-Duce, A; Sancho, V; Tornero-Esteban, P; Valverde, I; Villanueva-Peñacarrillo, ML | 1 |
| Beisswenger, PJ; Drummond, KS; Howell, SK; Mauer, M; Nelson, RG; Szwergold, BS | 1 |
| Dworacka, M; Winiarska, H | 1 |
| Del Prato, S; Hanefeld, M; Karrei, K; Koehler, C; Temelkova-Kurktschiev, T | 1 |
| Aasum, E; Edgley, A; Furler, SM; Larsen, T; Ljung, B; Oakes, ND; Severson, D; Thalén, P | 1 |
| Abramczyk, M; Borowska, M; Dworacka, M; Kuczynski, S; Szczawinska, K; Winiarska, H | 1 |
| Bilan, PJ; Caldwell, JS; Ilany, J; Kahn, CR; Kapur, S; Marette, A; Patti, ME | 1 |
| Gotoh, M; Hirooka, Y; Iguchi, A; Li, C; Yatoh, M | 1 |
| Buse, JB; Button, EA; Dungan, KM; Kato, S; Kelly, MM; Largay, J; Wittlin, S | 1 |
| Chan, CM; Chan, YW; Che, CT; Fung, KP; Ho, YY; Lam, FC; Lau, CB; Lau, CH; Lau, KM; Lau, TW; Leung, PC | 1 |
| Chen, R; Horiuchi, M; Iwai, M; Li, HS; Li, JM; Min, LJ; Mogi, M; Shiuchi, T; Suzuki, J; Tomochika, H; Tomono, Y; Tsuda, M; Wu, L | 1 |
| Okahata, S; Terauchi, Y; Tobe, K | 1 |
| Bechtel, L; Fortuna, JM; Kim, JH; McEntee, MF; Mostafa, OA; Moustaid-Moussa, N; Naggert, JK; Shoieb, AM; Soltani-Bejnood, M; Stewart, TP; Wang, L; Wang, Y | 1 |
| Asano, T; Hiramatsu, S; Ogo, A; Watanabe, A; Yoshizumi, H | 1 |
| Chung, SW; Doudet, D; Green, D; Kim, PT; Mui, AL; Ong, CJ; Parsons, R; Peacock, JW; Ruth, TJ; Sossi, V; Verchere, CB; Wong, JT; Yau, TY | 1 |
| Abramczyk, M; Bobkiewicz-Kozlowska, T; Borowska, M; Dworacka, M; Dworacki, G; Winiarska, H | 1 |
| Gao, Z; Liu, D; Liu, Z; Ye, J; Yin, J | 1 |
| Fei, X; Jing, F; Jun, L; Wang, Y; Yong, Z; Zhang, J; Zhu, M | 1 |
| Bobkiewicz-Kozłowska, T; Dworacka, M; Wegner, M; Winiarska, H | 1 |
| Allemann, S; Christ, E; Diem, P; Keller, U; Riesen, W; Schmidlin, K; Stahl, M; Stettler, C; Zwahlen, M | 1 |
| Button, EA; Gorczynska-Kosiorz, S; Klupa, T; Malecki, MT; Sieradzki, J; Skupien, J; Wanic, K | 1 |
| Arai, K; Kamada, T; Kawamori, R; Kishimoto, M; Kubota, M; Morishima, T; Yamasaki, Y | 1 |
| Benecke, H; Flier, JS; Hamann, A; Le Marchand-Brustel, Y; Lowell, BB; Susulic, VS | 1 |
| Abrams, L; Ciaraldi, TP; Henry, RR; Nikoulina, S | 1 |
| Marfaing-Jallat, P; Pénicaud, L; Portha, B | 1 |
| Azevedo, JL; Carey, JO; Dohm, GL; Morris, PG; Pories, WJ | 1 |
| Chusney, GD; Pickup, JC | 1 |
| Momose, T; Nishikawa, J; Ohtake, T; Sasaki, Y; Serezawa, T; Watanabe, T; Yokoyama, I | 1 |
| Cooper, DR; Farese, RV; Huang, LC; Standaert, ML; Suzuki, S; Toyota, T; Wang, Z; Yamada, K; Yang, Y; Zhang, C | 1 |
| Bergman, J; Haaparanta, M; Härkönen, R; Hartiala, J; Knuuti, MJ; Mäki, M; Nuutila, P; Ruotsalainen, U; Teräs, M; Voipio-Pulkki, LM; Wegelius, U; Yki-Järvinen, H | 1 |
| Niimura, K; Niwa, T; Ohara, M; Takeda, N; Tatematsu, A; Tomiyama, S; Yoshizumi, H | 1 |
| Haaparanta, M; Knuuti, MJ; Koivisto, VA; Nuutila, P; Ruotsalainen, U; Teräs, M; Voipio-Pulkki, LM; Wegelius, U | 1 |
| Beguinot, F; Beguinot, L; Di Finizio, B; Ferrara, A; Formisano, P; Miele, C; Petruzziello, A; Riccardi, G | 1 |
| Girard, J; Leturque, A; Loizeau, M; Salminen, M; Vaulont, S | 1 |
| Akaoka, L; Funato, H; Kawasaki, T; Miyashita, H; Ogata, N; Sekino, N; Tagaya, T; Yamanouchi, T | 1 |
| Gustavsson, J; Parpal, S; Strålfors, P | 1 |
| Pitkänen, E | 1 |
| Kobayashi, I; Tsukui, S | 1 |
| Fukumura, Y; Kobayashi, I; Tsukui, S | 1 |
| Fukasawa, H; Hotta, N; Kakuta, H; Koh, N; Naruse, K; Sakakibara, F; Takeuchi, N; Yamada, K; Yamada, T | 1 |
| Avogaro, A; Crepaldi, C; del Prato, S; Miola, M; Pavan, P; Tiengo, A; Valerio, A | 1 |
| Kawai, K; Kawakami, Y; Matsushima, T; Odawara, M; Okuda, Y; Sone, H; Yamaoka, T; Yamashita, K | 1 |
| Araki, N; Hamada, Y; Horiuchi, S; Hotta, N | 1 |
| Azukari, K; Kondo, M; Yoshida, T; Yoshioka, K | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Heine, RJ; Huitink, JM; Raymakers, PG; Van Lingen, A; Visser, CA; Visser, FC | 1 |
| Andreozzi, F; Beguinot, F; Caruso, M; Condorelli, G; Formisano, P; Miele, C; Oriente, F; Riccardi, G; Tocchetti, CG | 1 |
| Ahmad, F; Azevedo, JL; Cortright, R; Dohm, GL; Goldstein, BJ | 1 |
| Fujisawa, H; Hamada, Y; Hotta, N; Koh, N; Nakamura, J; Nakashima, E; Yago, H | 1 |
| Burcelin, R; Charron, MJ; Factor, SM; Geenen, DL; Houseknecht, K; Katz, EB; Li, J; Stenbit, AE; Tsao, TS | 1 |
| Attie, AD; Cartee, GD; Dumke, C; Ranheim, T; Schueler, KL | 1 |
| Lazarus, DD; Moldawer, LL; Trimble, LA | 1 |
| Arisaka, T; Honda, N; Kawamori, R; Kinoshita, J; Kurahashi, Y; Mochizuki, K; Nakamura, M; Tohjima, T; Watanabe, K; Yamamoto, S; Yoshimoto, T | 1 |
| Aso, Y; Inukai, T; Takemura, Y | 1 |
| Akaoka, I; Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
| Ikemoto, T; Ishikawa, Y; Saito, MN; Takeno, H; Tani, T; Watanabe, K | 1 |
| Beisswenger, PJ; Howell, SK; Lal, S; Szwergold, BS; Touchette, AD | 1 |
| Maeda, K; Matsumoto, Y; Odani, H; Shinzato, T; Usami, J | 1 |
| Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K | 1 |
| Döppler, H; Müller, G; Pfizenmaier, K; Storz, P; Wernig, A | 1 |
| Akanuma, Y | 1 |
| Chalfant, CE; Ciaraldi, TP; Cooper, DR; Henry, RR; Nikoulina, S; Watson, JE | 1 |
| Aiso, Y; Fujimori, S; Inoue, T; Kashiwabara, A; Kawasaki, T; Tanabe, T; Yamanouchi, T; Yoshimura, T | 1 |
| Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
| Bell, PA; Loskutoff, DJ; Pandey, M; Samad, F | 1 |
| Kahn, CR; Kulkarni, RN; Mauvais-Jarvis, F; Michael, MD; Virkamaki, A; Winnay, JN; Zisman, A | 1 |
| Nakata, M; Shioda, S; Yada, T | 1 |
| Bartolomei, MS; Birnbaum, MJ; Cho, H; Chu, Q; Crenshaw, EB; Kaestner, KH; Kim, JK; Mu, J; Shulman, GI; Thorvaldsen, JL | 1 |
| Chiozzi, P; Di Virgilio, F; Fellin, R; Fioretto, P; Passaro, A; Solini, A | 1 |
| Akanuma, Y; Kawakami, M; Ohashi, Y; Saito, Y; Tanaka, A; Yamada, N | 1 |
| Fang, J; Shen, Z; Shi, H; Yang, X; Zhu, X | 1 |
| Ebina, Y; Houchi, H; Ishizawa, K; Kishi, K; Minakuchi, K; Nakaya, Y; Takishita, E; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
| Daimon, M; Hirata, A; Igarashi, M; Kato, T; Ohnuma, H; Tominaga, M; Tsuchiya, H; Yamaguchi, H | 1 |
| Altomonte, J; Cai, W; Dong, HJ; Fisher, EA; Hofmann, SM; Li, Z; Thung, SN; Vlassara, H; Zeng, F | 1 |
| Akaoka, I; Minoda, S; Miyashita, H; Moromizato, H; Shinohara, T; Yamanouchi, T | 1 |
| Kalra, VK; Kumar, D; Nadler, JL; Natarajan, R; Rajeswari, P | 1 |
| Bruce, I; Fleet, GW; Johnson, LN; Martin, JL; Oikonomakos, NG; Orchard, MG; Papageorgiou, AC; Ramsden, NG; Ross, K; Veluraja, K | 1 |
| Chan, TM; Shargill, NS; Zeidler, A | 1 |
| Hisatomi, A; Ishii, H; Nakashima, N; Nawata, H; Umeda, F; Yamauchi, T | 1 |
| Atkinson, SM; Caro, JF; DiMarchi, R; Dohm, GL; Elton, CW; Flickinger, EG; Mooney, ND; Pories, WJ; Raju, MS | 1 |
| Andrews, KM; Gibbs, EM; Hutson, NJ; Kreutter, DK; Stevenson, RW | 1 |
| Berg, GW; Carson, RE; Eastman, RC; Gordon, MR; Larson, SM; Lillioja, S; Roth, J | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Minoda, S; Miyashita, H; Yabuuchi, M; Yamanouchi, T | 1 |
| Akanuma, H; Aoyagi, T; Kobayashi, T; Sakaguchi, T; Umezawa, H; Wada, T | 1 |
| Akanuma, H; Akanuma, Y; Fukuzawa, N; Morita, M; Yamanouchi, T | 1 |
| Atkinson, SM; Caro, JF; Dabbs, DJ; Dohm, GL; Elton, CW; Flickinger, EG; Fushiki, T; Meelheim, D; Pories, WJ; Tapscott, EB | 1 |
| Given, BD; Iwo, K; Kondo, M; Miyamura, K; Miyano, M; Nanjo, K; Nishimura, S; Okai, K; Sanke, T; Sowa, R | 1 |
| Akanuma, H; Akanuma, Y; Akaoka, I; Asano, T; Konishi, C; Yamanouchi, T | 1 |
| Krans, HM | 1 |
9 review(s) available for deoxyglucose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Extracellular Matrix Proteins; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Muscle, Skeletal; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Glycation and Antioxidants: Hand in the Glove of Antiglycation and Natural Antioxidants.
Topics: Antigens, Neoplasm; Antioxidants; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Lactoylglutathione Lyase; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Oxidative Stress; Plant Extracts; Polyphenols; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Prognosis; Prospective Studies; Serum Albumin | 2014 |
1,5-Anhydroglucitol in diabetes mellitus.
Topics: Animals; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Hyperglycemia; Kidney; Postprandial Period | 2013 |
1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glycated Hemoglobin; Humans; Hyperglycemia; Postprandial Period | 2002 |
[Postprandial hyperglycemia].
Topics: Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Evidence-Based Medicine; Glucose; Hyperglycemia; Hyperthyroidism; Insulin; Insulin Resistance; Insulin Secretion; Liver Cirrhosis; Oxidative Stress; Postprandial Period | 2006 |
[Physiopathology and therapy of diabetes mellitus].
Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic | 1999 |
Diabetes mellitus and insulin receptors.
Topics: Adipose Tissue; Animals; Biological Transport; Cell Membrane; Cell Nucleus; Coated Pits, Cell-Membrane; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocytes; Glucose; Humans; Insulin; Lymphocytes; Receptor, Insulin | 1985 |
27 trial(s) available for deoxyglucose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction.
Topics: Aged; Blood Glucose; Cerebral Infarction; Cholesterol, LDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diet Therapy; Exercise; Female; Functional Status; Glycated Hemoglobin; Glycemic Control; Hand Strength; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Muscle Strength; Patient Care Planning; Postprandial Period; Quality of Life; Treatment Outcome | 2020 |
Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin-Secreting Cells; Male; Middle Aged; Pancreatic Function Tests; Predictive Value of Tests | 2020 |
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Glyoxal; Humans; Irbesartan; Male; Middle Aged; Pyruvaldehyde; Tandem Mass Spectrometry; Time Factors; Treatment Outcome | 2021 |
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome | 2017 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2019 |
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Topics: Aged; Asian People; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol.
Topics: Blood Glucose; Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Follow-Up Studies; Glucosides; Glycated Hemoglobin; Humans; Prognosis; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Fibroblast Growth Factor 2; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Middle Aged; Triglycerides; Vascular Endothelial Growth Factor A | 2014 |
Circulating CD3+56+ cell subset in pre-diabetes.
Topics: Aged; Blood Glucose; CD3 Complex; CD56 Antigen; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Male; Middle Aged; Natural Killer T-Cells; Plaque, Atherosclerotic | 2014 |
Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged | 2014 |
Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Topics: Adolescent; Biomarkers; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Mass Screening; Obesity; Prediabetic State; Serum Albumin | 2016 |
Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
Topics: 1-Deoxynojirimycin; Analysis of Variance; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Postprandial Period | 2008 |
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.
Topics: Carbamates; Confidence Intervals; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Piperidines | 2011 |
Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Topics: Aged; Body Mass Index; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Materials Testing; Middle Aged; Needles; Netherlands; Obesity; Patient Preference; Practice Guidelines as Topic; Self Administration | 2011 |
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Japan; Male; Middle Aged; Monitoring, Ambulatory; Natriuretic Peptide, Brain; Nitriles; Pilot Projects; Plasminogen Activator Inhibitor 1; Postprandial Period; Predictive Value of Tests; Pyrazines; Pyrrolidines; Serum Albumin; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles; Vildagliptin | 2012 |
Usefulness of troglitazone administration to obese hyperglycaemic patients with near-normoglycaemia.
Topics: Adult; Aged; Blood Glucose; Chromans; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Obesity; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones | 2004 |
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide.
Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances | 2004 |
Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea.
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Caloric Restriction; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Multivariate Analysis; Patient Selection; Proinsulin; Sulfonylurea Compounds | 2006 |
Short term intensive insulin therapy improves insulin secretion significantly in type 2 diabetic patients.
Topics: Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Time Factors; Treatment Outcome | 2006 |
1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Isomerism; Male; Middle Aged; Regression Analysis | 1995 |
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Time Factors | 1996 |
Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels.
Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Female; Hospitalization; Humans; Isomerism; Linear Models; Male; Middle Aged; Patient Education as Topic; Prognosis; Time Factors | 1996 |
Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
Topics: Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Metformin; Middle Aged; Osmolar Concentration; Pyruvaldehyde; Sulfonylurea Compounds; Treatment Outcome | 1999 |
The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Kampo; Middle Aged | 2000 |
A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2001 |
175 other study(ies) available for deoxyglucose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Higher habitual intake of dietary dicarbonyls is associated with higher corresponding plasma dicarbonyl concentrations and skin autofluorescence: the Maastricht Study.
Topics: Aged; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diet; Diet Surveys; Dietary Exposure; Fasting; Female; Glycation End Products, Advanced; Glyoxal; Humans; Linear Models; Male; Mass Spectrometry; Middle Aged; Netherlands; Optical Imaging; Pyruvaldehyde; Skin | 2022 |
The correlation between amylin and insulin by treatment with 2-deoxy-D-glucose and/or mannose in rat insulinoma ins-1E cells.
Topics: Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Chaperone BiP; Glucose; Insulin; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Mannose; Pancreatic Neoplasms; Rats | 2021 |
Quantification of Glucose, fructose and 1,5-Anhydroglucitol in plasma of diabetic patients by ultra performance liquid chromatography tandem mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Fructose; Glucose; Humans; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |
Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects.
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Phenotype; Prediabetic State; Research Subjects | 2022 |
Dispersion of serum 1,5 anhydroglucitol values in patients with type 2 diabetes at goal of HbA1c.
Topics: Adolescent; Albuminuria; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Goals; Humans; Insulin; Middle Aged | 2023 |
Inverse association between 1,5-anhydroglucitol and neonatal diabetic complications.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Fructosamine; Glycated Hemoglobin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Risk Factors | 2019 |
1,5-Anhydroglucitol × glycated hemoglobin A
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Young Adult | 2020 |
Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province.
Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Reference Values; Uric Acid; Young Adult | 2020 |
Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Dinoprost; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rupture, Spontaneous; Ultrasonography, Interventional | 2020 |
Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Metabolism Disorders; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Control; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Time Factors | 2021 |
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.
Topics: Aged; Black or African American; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Minichromosome Maintenance Complex Component 6; Sodium-Glucose Transporter 1; White People | 2017 |
A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Glucosides; Glycosuria; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Male; Middle Aged; Mutation; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2017 |
A Hypothesis: Moderate Consumption of Alcohol Contributes to Lower Prevalence of Type 2 Diabetes Due to the Scavenging of Alpha-Dicarbonyls by Dietary Polyphenols.
Topics: Alcohol Drinking; Deoxyglucose; Diabetes Mellitus, Type 2; Diet; Free Radical Scavengers; Humans; Hydroxyl Radical; Life Style; Polyphenols | 2018 |
Immunochemical Study of the Effect of F
Topics: Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Glycogen; Glycogen Synthase; Hepatocytes; Male; Protein Transport; Rats; Rats, Sprague-Dawley | 2018 |
A decrease in serum 1,5-anhydroglucitol levels is associated with the presence of a first-degree family history of diabetes in a Chinese population with normal glucose tolerance.
Topics: Adult; Aged; Asian People; China; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Family; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Logistic Models; Male; Middle Aged; Serum Albumin; Young Adult | 2018 |
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid | 2019 |
The transcriptional response to oxidative stress is part of, but not sufficient for, insulin resistance in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Cell Line; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose; Insulin; Insulin Resistance; Mice; Oxidative Stress; Signal Transduction; Transcription, Genetic | 2018 |
Discrimination of different geographic varieties of Gymnema sylvestre, an anti-sweet plant used for the treatment of type 2 diabetes.
Topics: 4-Chloro-7-nitrobenzofurazan; Deoxyglucose; Diabetes Mellitus, Type 2; Gymnema sylvestre; Hypoglycemic Agents; India; Oleanolic Acid; Plant Extracts; Plant Leaves; Saponins; Vietnam | 2018 |
Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diacetyl; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde | 2019 |
A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Topics: Adult; Aged; Algorithms; Biomarkers; C-Reactive Protein; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucokinase; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Young Adult | 2019 |
Safety, Biodistribution, and Dosimetry of 123I-6-Deoxy-6-Iodo-D-Glucose, a Tracer of Glucose Transport, in Healthy and Diabetic Volunteers.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Male; Radiation Dosage; Radiopharmaceuticals; Renal Elimination; Tissue Distribution | 2019 |
Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC.
Topics: Adult; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde; Saliva | 2019 |
Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen.
Topics: Blood Chemical Analysis; Calibration; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Glyoxal; Humans; Isotope Labeling; Perchlorates; Phenylenediamines; Pyruvaldehyde; Tandem Mass Spectrometry; Time Factors | 2014 |
Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
Topics: Adipocytes; Administration, Oral; Animals; Blood Glucose; Body Weight; Cell Line; Cell Proliferation; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Ligands; Male; Mice; Protein Binding; Receptor, Insulin; Signal Transduction; Time Factors | 2013 |
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Mass Screening; Middle Aged; Predictive Value of Tests; Republic of Korea | 2013 |
High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation.
Topics: Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose; Glycolysis; Homeostasis; Humans; Hyperglycemia; Immunity, Innate; Interleukin-6; Lipopolysaccharides; Male; Microbial Viability; Neutrophil Activation; Neutrophils; Tetradecanoylphorbol Acetate | 2013 |
Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Regression Analysis; Uric Acid | 2013 |
Discovery of 6-deoxydapagliflozin as a highly potent sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Discovery; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Molecular Structure; Rats; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship | 2014 |
Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.
Topics: Administration, Oral; Angiotensin I; Animals; Animals, Newborn; Deoxyglucose; Diabetes Mellitus, Type 2; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Myocytes, Cardiac; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Saliva; Young Adult | 2014 |
Add-on treatment with teneligliptin ameliorates glucose fluctuations and improves glycemic control index in Japanese patients with type 2 diabetes on insulin therapy.
Topics: Aged; C-Reactive Protein; Combined Modality Therapy; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Monitoring, Ambulatory; Pilot Projects; Prospective Studies; Pyrazoles; Serum Albumin; Thiazolidines | 2014 |
Central alarin ameliorated insulin resistance of adipocytes in type 2 diabetic rats.
Topics: 4-Chloro-7-nitrobenzofurazan; Adipocytes; Adiponectin; Animals; Blood Glucose; Blotting, Western; Body Weight; Cell Membrane; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Galanin-Like Peptide; Gene Expression; Glucose Transporter Type 4; Injections, Intraventricular; Insulin Resistance; Male; Peptide Fragments; Protein Transport; Rats, Wistar; Retinol-Binding Proteins, Plasma; Reverse Transcriptase Polymerase Chain Reaction; Vesicle-Associated Membrane Protein 2 | 2014 |
Post-Glucose Load Plasma α-Dicarbonyl Concentrations Are Increased in Individuals With Impaired Glucose Metabolism and Type 2 Diabetes: The CODAM Study.
Topics: Atherosclerosis; Blood Glucose; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Glyoxal; Humans; Hyperglycemia; Male; Mass Spectrometry; Middle Aged; Postprandial Period; Pyruvaldehyde | 2015 |
1,5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Aged; Asian People; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Serum Albumin | 2015 |
1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.
Topics: Adult; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Male; Pregnancy; Pregnancy Complications | 2015 |
1,5-Anhydroglucitol: a new predictor of neonatal birth weight in diabetic pregnancies.
Topics: Biomarkers; Birth Weight; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Gestational Age; Glycated Hemoglobin; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy in Diabetics; Retrospective Studies | 2015 |
Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat.
Topics: Animals; Binding Sites; Coumaric Acids; Deoxyglucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Fructose; Glucose Transporter Type 2; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 3-beta; Hypoglycemic Agents; Liver; Male; Oxidation-Reduction; Promoter Regions, Genetic; Rats, Wistar; Sterol Regulatory Element Binding Protein 1 | 2015 |
Effect of a β-Hydroxyphosphonate Analogue of ʟ-Carnitine on Insulin-Sensitive and Insulin-Resistant 3T3-L1 Adipocytes.
Topics: 3T3-L1 Cells; 4-Chloro-7-nitrobenzofurazan; Adipocytes; Adipogenesis; Animals; Carnitine; Cell Differentiation; Deoxyglucose; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Mice | 2015 |
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes.
Topics: Adiponectin; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Diastole; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Japan; Linear Models; Male; Middle Aged; Pyrazoles; Thiazolidines; Ventricular Function, Left | 2016 |
Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Coronary Circulation; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Male; Middle Aged | 2015 |
Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol.
Topics: Canagliflozin; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Models, Biological; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2016 |
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.
Topics: Adipose Tissue; Animals; Blood Glucose; Blotting, Western; Body Composition; Brain; Carbon Radioisotopes; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Ependymoglial Cells; Fibroblast Growth Factor 1; Forkhead Box Protein O1; Glucose Tolerance Test; Heart; Heat-Shock Proteins; Hyperglycemia; Hypothalamus; Injections, Intraventricular; Liver; Male; Mice; Mice, Knockout; Mice, Obese; Molecular Chaperones; Muscle, Skeletal; Myocardium; Neoplasm Proteins; Proto-Oncogene Proteins c-fos; Rats; Rats, Zucker; Real-Time Polymerase Chain Reaction; Receptor, Insulin; Remission Induction | 2016 |
The inhibiting effect of the Coptis chinensis polysaccharide on the type II diabetic mice.
Topics: 3T3-L1 Cells; 4-Chloro-7-nitrobenzofurazan; Adenylate Kinase; Adipocytes; Adipokines; Animals; Blood Glucose; Body Weight; Coptis; Cytokines; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Fasting; Feeding Behavior; Gene Expression Regulation; Gluconeogenesis; Insulin; Lipids; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Polysaccharides | 2016 |
The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
Topics: Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Republic of Korea; Serum Albumin | 2016 |
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease.
Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Topics: Adolescent; Area Under Curve; Biomarkers; Blood Glucose; Child; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Monitoring, Ambulatory; Prediabetic State; Reproducibility of Results; Serum Albumin | 2017 |
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
Topics: Aged; Atherosclerosis; Blood Glucose; Carotid Intima-Media Thickness; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Oxidation-Reduction; Pyruvaldehyde; Triglycerides | 2017 |
Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Retinal Detachment | 2017 |
Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Retrospective Studies; ROC Curve; Uric Acid; Young Adult | 2017 |
Determination of glycemic monitoring marker 1,5-anhydroglucitol in plasma by liquid chromatography-electrospray tandem mass spectrometry.
Topics: Biomarkers; Case-Control Studies; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Linear Models; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sex Characteristics; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2008 |
Cecropia obtusifolia Bertol and its active compound, chlorogenic acid, stimulate 2-NBDglucose uptake in both insulin-sensitive and insulin-resistant 3T3 adipocytes.
Topics: 4-Chloro-7-nitrobenzofurazan; Adipocytes; Adipogenesis; Analysis of Variance; Animals; Cecropia Plant; Cell Line; Chlorogenic Acid; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin; Insulin Resistance; Mexico; Mice; Phytotherapy; Plant Extracts; Plant Structures | 2008 |
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al.
Topics: Albuminuria; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Multivariate Analysis; Postprandial Period | 2008 |
1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
Topics: Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Linear Models; Male; Middle Aged; Prediabetic State; Young Adult | 2009 |
Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status.
Topics: Acetyl-CoA Carboxylase; Age Factors; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Biopsy; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; GTPase-Activating Proteins; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Phosphorylation; Protein Kinases; Ribonucleotides; Young Adult | 2009 |
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Black People; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Ethnicity; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Racial Groups; White People | 2009 |
Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antimetabolites; Antioxidants; Blood Glucose; Cyclic N-Oxides; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Oxidative Stress; Pravastatin; Spin Labels; Tetrazoles | 2009 |
Screening for type 2 diabetes in obese youth.
Topics: Adolescent; Age Factors; Blood Glucose; Body Mass Index; Child; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Mass Screening; Obesity; Predictive Value of Tests; ROC Curve; Texas | 2009 |
Apelin is necessary for the maintenance of insulin sensitivity.
Topics: Adipokines; AMP-Activated Protein Kinases; Animals; Apelin; Carrier Proteins; Cells, Cultured; Chromones; Deoxyglucose; Diabetes Mellitus, Type 2; Dietary Sucrose; Enzyme Inhibitors; Hyperinsulinism; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Muscle, Skeletal; Myoblasts; NG-Nitroarginine Methyl Ester; Obesity; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Leptin; Signal Transduction; Tritium | 2010 |
Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
Topics: Adolescent; Adult; Age of Onset; Blood Glucose; Body Mass Index; Child; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucose Tolerance Test; Glycated Hemoglobin; Hepatocyte Nuclear Factor 1-alpha; Humans; Insulin-Secreting Cells; Mutation; Prognosis; ROC Curve; Young Adult | 2010 |
3beta-taraxerol of Mangifera indica, a PI3K dependent dual activator of glucose transport and glycogen synthesis in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Cell Survival; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Activation; Glucose; Glycogen; Humans; Insulin Resistance; Mangifera; Mice; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Plant Extracts | 2010 |
The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndrome.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Blood Glucose; Blotting, Western; Body Weight; Cells, Cultured; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Genotype; Glucose; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Mexican Americans; Muscle Fibers, Skeletal; Muscle, Skeletal; Myoblasts; Obesity; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2010 |
Acute oxidative stress can reverse insulin resistance by inactivation of cytoplasmic JNK.
Topics: Animals; Cytoplasm; Deoxyglucose; Diabetes Mellitus, Type 2; Dual-Specificity Phosphatases; Enzyme Activation; Gene Expression Regulation, Enzymologic; Insulin; Insulin Resistance; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase Phosphatases; Models, Biological; Muscles; Oxidative Stress; Signal Transduction | 2010 |
Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70.
Topics: Aged; Arteries; Biphasic Insulins; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin, Isophane; Male; Middle Aged | 2011 |
Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged | 2010 |
Vomifoliol 9-O-α-arabinofuranosyl (1→6)-β-D-glucopyranoside from the leaves of Diospyros Kaki stimulates the glucose uptake in HepG2 and 3T3-L1 cells.
Topics: 3T3-L1 Cells; 4-Chloro-7-nitrobenzofurazan; Animals; Butanols; Cell Differentiation; Cyclohexanols; Cyclohexanones; Deoxyglucose; Diabetes Mellitus, Type 2; Diospyros; Disaccharides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hep G2 Cells; Humans; Hypoglycemic Agents; Mice | 2011 |
Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Monitoring, Physiologic | 2013 |
Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects.
Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged | 2012 |
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.
Topics: Blood Glucose; Chronic Disease; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Kidney Diseases | 2012 |
A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Blood Glucose Self-Monitoring; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Young Adult | 2012 |
The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Serum Albumin | 2012 |
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.
Topics: Albuminuria; Biomarkers; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Prevalence; Republic of Korea; Risk Factors | 2012 |
Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Topics: Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period | 2011 |
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Glargine; Insulin Lispro; Insulin, Long-Acting; Male; Middle Aged; Treatment Outcome; Weight Gain | 2012 |
Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Bradykinin; Cell Membrane; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Galanin; Gene Expression Regulation; Glucose Clamp Technique; Glucose Transporter Type 4; Hypothalamus; Injections, Intraventricular; Insulin; Insulin Resistance; Male; Peptide Fragments; Physical Conditioning, Animal; Rats; Rats, Wistar; RNA, Messenger; Triglycerides | 2012 |
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Fructosamine; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Remission Induction; Time Factors | 2012 |
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.
Topics: 3T3-L1 Cells; Adipocytes; Administration, Oral; Animals; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Humans; Inflammation; Insulin Receptor Substrate Proteins; Macrophages; Metabolic Syndrome; Mice; Oxidative Stress; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sirtuin 1 | 2012 |
Predicting outcomes and assessing control with alternate glycemic markers.
Topics: Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Male | 2012 |
Protective effects of dietary 1,5-anhydro-D-glucitol as a blood glucose regulator in diabetes and metabolic syndrome.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Cholesterol; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Glycosuria; Hyperglycemia; Intestines; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL | 2013 |
Sutherlandia frutescens prevents changes in diabetes-related gene expression in a fructose-induced insulin resistant cell model.
Topics: Cell Line; Deoxyglucose; Diabetes Mellitus, Type 2; Fabaceae; Fructose; Gene Expression Profiling; Glucose Oxidase; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Resistance; Plant Extracts | 2013 |
Gas chromatographic-mass spectrometric determination of erythrocyte 3-deoxyglucosone in diabetic patients.
Topics: Adolescent; Adult; Case-Control Studies; Child; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocytes; Female; Gas Chromatography-Mass Spectrometry; Glycated Hemoglobin; Humans; Male; Reference Standards | 2002 |
ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Blood Glucose; Bradykinin; Cell Line; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Insulin Receptor Substrate Proteins; Insulin Resistance; Kinetics; Male; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nitric Oxide; Phosphoproteins; Phosphorylation; Protein Transport; Thiazepines | 2002 |
Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.
Topics: Androstadienes; Animals; Biological Transport; CD36 Antigens; Deoxyglucose; Diabetes Mellitus, Type 2; Electric Stimulation; Enzyme Inhibitors; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Membrane Glycoproteins; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Organic Anion Transporters; Palmitates; Phloretin; Rats; Rats, Inbred Lew; Succinimides; Transport Vesicles; Wortmannin | 2002 |
Enhancement of glucose uptake in 3T3-L1 adipocytes by Toona sinensis leaf extract.
Topics: 3T3 Cells; Adipocytes; Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose; In Vitro Techniques; Insulin; Mice; Plant Leaves | 2003 |
Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking.
Topics: 3T3 Cells; Adipocytes; Animals; Carrier Proteins; Cell Membrane; CHO Cells; Cloning, Molecular; Cricetinae; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Humans; Insulin; Intracellular Signaling Peptides and Proteins; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Protein Binding; Protein Structure, Tertiary; Protein Transport | 2003 |
Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Crosses, Genetic; Deoxyglucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Intake; Gene Expression Regulation; Glucose Transporter Type 4; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Obese; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Pyridines; Signal Transduction; Superoxides; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2004 |
Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructose; Glycated Hemoglobin; Humans; Male; Middle Aged; Postprandial Period; Prevalence | 2004 |
Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Longitudinal Studies; Time Factors | 2004 |
A new model of primary human adipocytes reveals reduced early insulin signalling in type 2 diabetes.
Topics: Adipocytes; Aged; Case-Control Studies; Cell Differentiation; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperinsulinism; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors | 2004 |
Circadian rhythm of glucose uptake in cultures of skeletal muscle cells and adipocytes in Wistar-Kyoto, Wistar, Goto-Kakizaki, and spontaneously hypertensive rats.
Topics: Adipocytes; Animals; Biological Transport, Active; Cells, Cultured; Circadian Rhythm; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose; Hypertension; Insulin; Muscle, Skeletal; Phloretin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Staurosporine | 2004 |
Exercise modulates myocardial protein kinase B/Akt in Zucker obese rats.
Topics: Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Myocytes, Cardiac; Obesity; Phosphorylation; Physical Conditioning, Animal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker | 2005 |
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
Topics: Adipocytes; Animals; Biological Transport; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Glucose-6-Phosphate Isomerase; Glycoproteins; Humans; Insulin Resistance; Lipectomy; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Obesity; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases | 2005 |
Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle.
Topics: Animals; Biological Transport; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Muscle, Skeletal; Organ Culture Techniques; Peptide Fragments; Protein Kinases; Protein Precursors; Rats; Rats, Wistar | 2005 |
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Ascorbic Acid; Blood Glucose; Chromatography, High Pressure Liquid; Creatine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Kidney; Lysine; Male; Oxidation-Reduction; Protease Inhibitors; Ramipril; Rats; Rats, Zucker; Spectrometry, Fluorescence | 2005 |
Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements.
Topics: Aged; Animals; Arachidonic Acid; Biopsy; Blotting, Western; Cell Nucleus; CHO Cells; Chromatography, High Pressure Liquid; Cricetinae; Deoxyglucose; Diabetes Mellitus, Type 2; DNA; DNA Primers; Dose-Response Relationship, Drug; Fatty Acids; Female; Gene Deletion; Gene Expression Regulation; Genes, Reporter; Glucose Transporter Type 4; HeLa Cells; Humans; Linoleic Acid; Lipids; Male; Middle Aged; Models, Biological; Muscles; Myocardium; Oleic Acid; PPAR gamma; Promoter Regions, Genetic; Protein Binding; Proteins; Rats; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stearic Acids; Time Factors; Transcription, Genetic | 2005 |
GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients.
Topics: Aged; Aged, 80 and over; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Exenatide; Female; Glucose; Glycogen; Glycogen Synthase; Humans; Immunoblotting; Insulin; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Cells; Peptide Fragments; Peptides; Phosphatidylinositol 3-Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Venoms | 2005 |
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.
Topics: Adolescent; Adult; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Susceptibility; Glycated Hemoglobin; Humans; Indians, North American; Oxidative Stress; Pyruvaldehyde; Risk Factors | 2005 |
The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular System; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Multivariate Analysis; Regression Analysis | 2005 |
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening.
Topics: Blood Glucose; Carotid Artery, Common; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Topics: Animals; Blood Glucose; Body Weight; Butyrates; Carbon Radioisotopes; Deoxyglucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Genotype; Heart; Insulin; Lactic Acid; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Organ Size; Oxidation-Reduction; Receptors, Cell Surface; Receptors, Leptin; Triglycerides; Tritium | 2006 |
Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level.
Topics: Amino Acids; Animals; Biological Transport; Creatine Kinase; Deoxyglucose; Diabetes Mellitus, Type 2; Dietary Fats; Enhancer Elements, Genetic; Glucose; Glucose Intolerance; Homeostasis; Insulin; Insulin Resistance; Lipid Metabolism; Lipoprotein Lipase; Mice; Mice, Transgenic; Muscle, Skeletal; Promoter Regions, Genetic; ras Proteins; Transcriptional Activation; Triglycerides; Up-Regulation | 2006 |
Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Sex Characteristics; Uric Acid | 2005 |
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Humans; Hyperglycemia; Monitoring, Ambulatory; Monitoring, Physiologic; Postprandial Period; Reproducibility of Results | 2006 |
Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis.
Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Fibroblasts; Glucose; Glucose Tolerance Test; Homeostasis; Humans; Mice; Microvilli; Phytotherapy; Plants, Medicinal; Rabbits; Rats; Rats, Wistar | 2007 |
Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antimetabolites; Antioxidants; Azetidinecarboxylic Acid; Blood Glucose; Calcium Channel Blockers; Cyclic N-Oxides; Deoxyglucose; Diabetes Mellitus, Type 2; Dihydropyridines; Glucose Intolerance; Glucose Tolerance Test; Glucose Transporter Type 4; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Phosphoproteins; Spin Labels; Superoxides; Tetrazoles | 2006 |
Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Breeding; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Male; Mice; Mice, Inbred Strains; Muscle, Skeletal; Pancreas; Phenotype; Time Factors; Triglycerides | 2006 |
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity.
Topics: Animals; Blood Glucose; Crosses, Genetic; Deoxyglucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Genetic Carrier Screening; Glucose; Glucose Tolerance Test; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; PTEN Phosphohydrolase | 2007 |
Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.
Topics: Acute Disease; Aged; Antigens, CD; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Lymphocyte Count; Male; Middle Aged; Risk Factors; Tunica Intima | 2007 |
Berberine improves glucose metabolism through induction of glycolysis.
Topics: 3T3-L1 Cells; Adenosine Monophosphate; Adenosine Triphosphate; Adipocytes; AMP-Activated Protein Kinases; Animals; Berberine; Deoxyglucose; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose; Glucose Intolerance; Glycolysis; Insulin Resistance; Lactic Acid; Male; Mice; Mitochondria; Multienzyme Complexes; Obesity; Oxygen Consumption; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar | 2008 |
A novel fully enzymatic method for determining glucose and 1,5-anhydro-D-glucitol in serum of one cuvette.
Topics: Blood Glucose; Chemistry Techniques, Analytical; Deoxyglucose; Diabetes Mellitus, Type 2; Glucokinase; Glucosephosphate Dehydrogenase; Humans; Models, Biological; Reproducibility of Results | 2008 |
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-12; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Proinsulin; Regression Analysis; Sulfonylurea Compounds | 2008 |
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.
Topics: Aged; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Middle Aged; Outpatients; Postprandial Period; Reproducibility of Results; Switzerland | 2008 |
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Mutation; Poland; Reference Values; Registries; Sex Characteristics | 2008 |
Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
Topics: Adipose Tissue; Adipose Tissue, Brown; Aging; Animals; Biological Transport; Blood Glucose; Cell Membrane; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diphtheria Toxin; Female; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Mice; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Receptor, Insulin; Reference Values; RNA, Messenger; Sex Characteristics; Tumor Necrosis Factor-alpha | 1995 |
Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
Topics: Adult; Biological Transport; Biopsy, Needle; Cell Fusion; Cells, Cultured; Creatine Kinase; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose; Glycogen; Glycogen Synthase; Glycolysis; Humans; Insulin; Insulin-Like Growth Factor I; Middle Aged; Muscle, Skeletal; Pyruvate Dehydrogenase Complex; Receptor, IGF Type 1; Receptor, Insulin; Reference Values | 1995 |
Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats.
Topics: Animals; Avoidance Learning; Brain Chemistry; Brain Stem; Deoxyglucose; Diabetes Mellitus, Type 2; Drinking; Eating; Energy Metabolism; Female; Glucose; Hypothalamus; Insulin; Rats; Rats, Wistar; Taste | 1995 |
Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle.
Topics: Adult; Biological Transport; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoxia; Insulin; Insulin Resistance; Muscle, Skeletal; Obesity | 1995 |
Serum 1,5-anhydro-D-glucitol assay by high performance anion exchange chromatography.
Topics: Blood Glucose; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Reference Values; Specimen Handling | 1994 |
Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardium; Tomography, Emission-Computed | 1995 |
Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.
Topics: Adipocytes; Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Activation; Glycerol-3-Phosphate O-Acyltransferase; Inositol Phosphates; Insulin; Male; Phosphatidylinositols; Polysaccharides; Rats; Rats, Mutant Strains; Rats, Wistar | 1994 |
Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Topics: Adult; Aged; Coronary Angiography; Deoxyglucose; Diabetes Mellitus, Type 2; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Nicotinic Acids; Pyrazines; Radionuclide Ventriculography; Tomography, Emission-Computed | 1994 |
Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
Topics: Adult; Aged; Biomarkers; Cross-Linking Reagents; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Gas Chromatography-Mass Spectrometry; Humans; Maillard Reaction; Male; Middle Aged; Reference Values | 1993 |
Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography.
Topics: Coronary Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Male; Middle Aged; Muscles; Myocardium; Tomography, Emission-Computed | 1993 |
Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation.
Topics: Adult; Aminobutyrates; Cells, Cultured; Cytochalasin B; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fibroblasts; Glucose; Glutamine; Glycogen Synthase; Humans; Insulin; Male; Middle Aged; Phosphorylation; Phosphotransferases; Point Mutation; Receptor, Insulin; Tetradecanoylphorbol Acetate | 1993 |
Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle.
Topics: Adipose Tissue; Animals; Biological Transport; Blood Glucose; Blotting, Northern; Blotting, Western; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Injections, Intraperitoneal; Insulin; Male; Mice; Mice, Inbred CBA; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; RNA, Messenger | 1996 |
Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes.
Topics: Adenosine Deaminase; Adipocytes; Animals; Biological Transport; Cell Fractionation; Cell Membrane; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Epididymis; Glucose; Glucose Transporter Type 4; Insulin; Isoproterenol; Kinetics; Male; Models, Biological; Monosaccharide Transport Proteins; Muscle Proteins; Rats; Rats, Sprague-Dawley | 1996 |
Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.
Topics: Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fructose; Gas Chromatography-Mass Spectrometry; Humans; Isomerism; Mannitol; Mannose | 1996 |
Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; False Positive Reactions; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Japan; Mass Screening; Middle Aged; Multivariate Analysis; Obesity; Probability; Regression Analysis; Reproducibility of Results; Rural Population; Stereoisomerism | 1995 |
Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycosuria; Humans; Isomerism; Middle Aged; Nuclear Family; Reference Values | 1996 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Trisaccharides | 1996 |
Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 2; Ethanol; Fatty Acids, Nonesterified; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forearm; Glucose; Humans; Insulin; Lactic Acid; Male; Middle Aged; Muscles; Osmolar Concentration; Reference Values; Triglycerides | 1996 |
Role of polyol pathway in nonenzymatic glycation.
Topics: Aldehyde Reductase; Animals; Cattle; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Erythrocytes; Fructosephosphates; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Polymers; Rhodanine; Serum Albumin, Bovine; Thiazolidines | 1996 |
Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
Topics: Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Inositol; Isomerism; Male; Middle Aged | 1997 |
Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
Topics: Aged; Blood Glucose; Coronary Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1997 |
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Topics: Adult; Aged; Biological Transport; Blood Glucose; Cell Membrane; Cells, Cultured; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Fibroblasts; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Insulin; Kinetics; Male; Microsomes; Middle Aged; Monosaccharide Transport Proteins; Muscle, Skeletal; Obesity; Receptor, Insulin; Reference Values; Regression Analysis; RNA, Messenger; Skin; Thinness; Transcription, Genetic | 1997 |
Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
Topics: Adult; Body Weight; Cell Fractionation; Chromatography, Gel; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Immunoblotting; Insulin; Insulin Resistance; Middle Aged; Muramidase; Muscle, Skeletal; Obesity; Phosphoprotein Phosphatases; Phosphorylation; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Receptor, Insulin; Receptors, Cell Surface; Substrate Specificity | 1997 |
Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients.
Topics: Adult; Blood Glucose; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Reference Values | 1997 |
GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.
Topics: Animals; Blood Glucose; Blood Pressure; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Heterozygote; Insulin; Insulin Resistance; Insulin Secretion; Isoproterenol; Male; Mice; Mice, Knockout; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myocardium; Time Factors | 1997 |
Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice.
Topics: Adipose Tissue; Animals; Biological Transport, Active; Body Weight; Crosses, Genetic; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Female; Genotype; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperlipidemias; Hypoxia; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Organ Size; Sex Characteristics | 1997 |
The metabolic effects of pokeweed mitogen in mice.
Topics: Animals; B-Lymphocytes; Blood Glucose; Cell Line; Cytokines; Deoxyglucose; Diabetes Mellitus, Type 2; Eating; Insulin; Lactic Acid; Lipids; Male; Mice; Mice, Inbred Strains; Mice, SCID; Muscles; Obesity; Pokeweed Mitogens; T-Lymphocytes; Weight Loss | 1998 |
Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Arachidonate 12-Lipoxygenase; Arachidonic Acid; Blood Glucose; Blood Platelets; Body Mass Index; Cytosol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Fructose; Glucose; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Characteristics | 1998 |
Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
Topics: Adult; Albuminuria; beta 2-Microglobulin; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Solubility; Thrombomodulin | 1998 |
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Regression Analysis; Sulfonylurea Compounds; Time Factors; Triglycerides | 1998 |
Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals.
Topics: Administration, Oral; Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Inbred Strains; Oxazoles; Phenylalanine; Rats; Rats, Inbred Strains; Rats, Wistar | 1998 |
Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
Topics: 2-Naphthylamine; Aging; Arginine; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Glyoxal; Humans; Kidney Failure, Chronic; Lysine; Mass Spectrometry; Matched-Pair Analysis; Middle Aged; Pyruvaldehyde; Reactive Oxygen Species; Sensitivity and Specificity; Uremia | 1999 |
Economic evaluation of alternative indicators for screening for diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1999 |
Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Topics: Animals; Biological Transport, Active; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Down-Regulation; Fatty Acids, Nonesterified; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Microsomes; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myristic Acid; Obesity; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction; Tumor Necrosis Factor-alpha | 1999 |
Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dysregulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity.
Topics: Adult; Animals; Cell Differentiation; Cell Line; Deoxyglucose; Diabetes Mellitus, Type 2; Gene Expression; Glycogen Synthase; Humans; Insulin; Isoenzymes; Middle Aged; Muscle, Skeletal; Protein Kinase C; Rats; RNA, Messenger; Transfection | 2000 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |
Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes.
Topics: Adipocytes; Animals; Biological Transport; Blood Glucose; Cardiovascular Diseases; Cell Line; Deoxyglucose; Diabetes Mellitus, Type 2; Hyperinsulinism; In Situ Hybridization; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Plasminogen Activator Inhibitor 1; RNA, Messenger; Signal Transduction; Up-Regulation | 2000 |
A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.
Topics: Acute-Phase Reaction; Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Glucose; Glucose Tolerance Test; Glycogen; Injections, Intraperitoneal; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Lipid Metabolism; Mice; Mice, Knockout; Muscle, Skeletal; Receptor, Insulin; Reference Values | 2000 |
Insulinotropin PACAP potentiates insulin action. Stimulation of glucose uptake in 3T3-LI adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport, Active; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Synergism; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Mice; Models, Biological; Neuropeptides; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Precursors; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Receptors, Pituitary Hormone | 2000 |
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).
Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Gene Targeting; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Homeostasis; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Skeletal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction | 2001 |
A defect in glycogen synthesis characterizes insulin resistance in hypertensive patients with type 2 diabetes.
Topics: Albuminuria; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fibroblasts; Glucose; Glucose Clamp Technique; Glycogen; Glycogen Synthase; Humans; Hypertension; Insulin; Insulin Resistance; Liver; Male; Middle Aged | 2001 |
Serum 1,5-anhydro-D-glucitol as a new clinical marker for glucose metabolism in type 2 diabetics.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Male; Middle Aged | 1999 |
Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Adipocytes; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Activation; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Heart Rate; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Physical Conditioning, Animal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF | 2001 |
Candesartan inhibits carotid intimal thickening and ameliorates insulin resistance in balloon-injured diabetic rats.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Carotid Artery, Common; Cells, Cultured; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Insulin Resistance; Male; Muscle, Smooth, Vascular; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Tetrazoles; Tunica Intima | 2001 |
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.
Topics: Adipose Tissue; Animals; Biological Transport; Blood Glucose; Body Weight; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Disease Models, Animal; Glucose Tolerance Test; Glycation End Products, Advanced; Insulin; Kidney Function Tests; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Obesity; Reference Values | 2002 |
Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Topics: Adult; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycosuria; Hemoglobin A; Humans; Male; Middle Aged; Osmolar Concentration | 1992 |
Glucose induces lipid peroxidation and inactivation of membrane-associated ion-transport enzymes in human erythrocytes in vivo and in vitro.
Topics: Adenosine Triphosphatases; Blood; Calcium-Transporting ATPases; Carbohydrates; Cyclooxygenase Inhibitors; Deoxyglucose; Diabetes Mellitus, Type 2; Erythrocyte Indices; Erythrocytes; Glucose; Humans; Hydroxyeicosatetraenoic Acids; Lipid Metabolism; Lipid Peroxidation; Lipoxygenase Inhibitors; Malondialdehyde; Sodium-Potassium-Exchanging ATPase | 1991 |
Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Drug Design; Glucose; Hypoglycemic Agents; Kinetics; Models, Molecular; Phosphorylase b; Protein Binding; X-Ray Diffraction | 1991 |
Peripheral insulin insensitivity in the hyperglycemic athymic nude mouse: similarity to noninsulin-dependent diabetes mellitus.
Topics: Animals; Biological Transport, Active; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Hyperglycemia; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Mice; Mice, Nude; Muscles | 1991 |
Serum 1,5-anhydro-D-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Models, Biological; Regression Analysis; Time Factors | 1991 |
IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.
Topics: Adult; Biological Transport; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucose; Humans; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Muscles; Obesity; Receptors, Cell Surface; Receptors, Somatomedin; Somatomedins | 1990 |
Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes.
Topics: Adipose Tissue; Animals; Benzopyrans; Biological Transport; Cell Line; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose; Insulin; Insulin Resistance; Oxidation-Reduction; Receptor, Insulin; Sulfonylurea Compounds; Temperature; Thiazoles; Thiazolidinediones | 1990 |
Brain glucose metabolism in noninsulin-dependent diabetes mellitus: a study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp.
Topics: Adult; Brain; Deoxyglucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Indians, North American; Insulin; Kinetics; Tomography, Emission-Computed | 1990 |
Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Fasting; Female; Glycosuria; Humans; Insulin; Male; Middle Aged; Pregnancy; Pregnancy in Diabetics | 1989 |
Changes in relationship between blood glucose level and plasma 1,5-anhydroglucitol level in KK mice.
Topics: Animals; Blood Glucose; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin Resistance; Mice; Mice, Inbred Strains | 1989 |
Non-insulin-dependent diabetes.
Topics: Adrenalectomy; Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Humans; Hypothalamus; Insulin; Insulin Secretion; Rats; Sympathetic Nervous System | 1985 |
Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients.
Topics: Adult; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glycosuria; Humans; Isomerism; Reference Values | 1988 |
An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.
Topics: 3-O-Methylglucose; Adult; Biological Transport; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Tolerance Test; Humans; In Vitro Techniques; Insulin Resistance; Male; Methylglucosides; Muscles; Obesity, Morbid; Time Factors | 1988 |
Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
Topics: Adipose Tissue; Animals; Base Sequence; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; DNA; DNA, Recombinant; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Middle Aged; Rats; Receptor, Insulin | 1986 |
Reduction and recovery of plasma 1,5-anhydro-D-glucitol level in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Glucose; C-Peptide; Deoxy Sugars; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged; Rats | 1987 |